The California-based company provides a range of services that include imaging joint ventures, help with center acquisitions, and outsourced radiology assistance for hospitals.
Experts from Emory University discovered a correlation after studying national Medicare imaging trends over a 12-year period and lining them up against lawsuit payouts.
The company has seen an uptick in COVID-19 cases in core markets, but third quarter volumes continue to recover from the steep drops seen in the spring.
The analysis was sponsored by the Alzheimer's Association and included more than 25,000 Medicare beneficiaries, with researchers exploring whether positron emission tomography could curb costs.
The decline in business was worse in April at 50%, but levels reached upward of 90% of pre-COVID volume by the end of June, the Florida physician firm reported.